Migraine
Migraine is a type of headache characterized by intense, throbbing pain, often accompanied by nausea, vomiting, and sensitivity to light and sound. Some people experience warning signs known as aura before the headache begins.
Migraine Prevention in Kids: Rimegepant Study
We are testing a new medication, rimegepant, to see if it helps reduce migraine days in children and adolescents aged 6 to under 18. The study compares its effects to a placebo to understand its potential benefits.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 6 and 17 years old?
- Do you have a history of migraines with at least 6 migraine days in the last month?
- Do you weigh more than 15 kg?
- Have you had any major psychiatric issues or suicidal thoughts in the last 30 days?
- Do you have a history of severe drug allergies or hypersensitivity?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Des Enfants
Pôle de Pédiatrie (Equipe Ressource Régionale de Soins Palliatifs Pédiatriques Midi-Pyrénées)
Blagnac, France
Centre Hospitalier Intercommunal Creteil
Pédiatrie Générale
Créteil, France
Centre Hospitalier Universitaire De Montpellier
Service de Neuropédiatrie
Montpellier, France
Sponsor: Pfizer Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.